![]() | |
Clinical data | |
---|---|
Other names | Iodocholesterol; 19-Iodocholesterol; Iodocholesterol (131I); 19-Iodocholest-5-en-3β-ol |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.048.618 ![]() |
Chemical and physical data | |
Formula | C27H45IO |
Molar mass | 512.560 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Iodocholesterol, or 19-iodocholesterol, also as iodocholesterol (131I) (INN) and NP-59, is a derivativeofcholesterol with an iodine atom in the C19 position and a radiopharmaceutical.[1][2] When the iodine atom is a radioactive isotope (iodine-125oriodine-131), it is used as an adrenal cortex radiotracer in the diagnosis of patients suspected of having Cushing's syndrome, hyperaldosteronism,[3] pheochromocytoma, and adrenal remnants following total adrenalectomy.[1][2]
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
![]() | This nuclear medicine article is a stub. You can help Wikipedia by expanding it. |